RadNet Q2 2026 revenue jumps 25% to a record $622.7M, but the company warns of a wider H1 net loss as Digital Health investments and interest costs pressure bottom-line results.
RadNet's record Q2 revenue and raised full-year guidance suggest the core imaging business fundamentals remain strong despite profitability headwinds. The 25% revenue jump, 238 bps mix shift to advanced imaging, and 21% procedural growth may attract growth investors, but the widened six-month net loss, lower adjusted EPS, and dilution from share count growth are clear profit-related drags.
The market is likely focusing on the better-than-expected revenue growth, record quarterly revenue, and raised full-year EBITDA guidance rather than one-off charges like acquisition costs and debt refinancing losses.
RadNet's Q2 2026 revenue climbed 25% to $622.7M with advanced imaging mix improving to 29.9% of volumes she pushed Imaging Center EBITDA margins to 16.1%. However, adjusted EPS fell to $0.29 from $0.34 and H1 net loss widened to $25.5M, masking the record top-line performance. Digital Health ARR nearly doubled to $105.5M, but segment EBITDA dropped as the company invests in commercialization; hedge fund positions also trimmed 30% during the quarter.
Investors focused on record revenue and raised guidance rather than the $25.9M H1 loss driven by acquisition costs, debt refinancing, and amortization. Hedge fund holdings dropped from 30 to 22 funds, but ARR growth in Digital Health created longer-term optimism.
ARR increased from $53.5M at June 30, 2025 to $105.5M by June 30, 2026 — a 97% jump. External customers now account for a growing share of that revenue, contributing to the segment's 56.5% YoY growth.